Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
暂无分享,去创建一个
J. Goldberg | M. Jerkeman | M. Dreyling | J. Vermeulen | M. Trněný | G. Hess | S. Rule | F. Offner | C. Thieblemont | M. Witzens‐Harig | W. Jurczak | Seok-Goo Cho | I. Bence-Bruckler | C. Rusconi | D. Caballero | S. Cho | C. João | W. Zhou | T. Henninger | S-G Cho | I. Bence‐Bruckler